Hengyu Li
4PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Sep 14, 2023
HLF promotes ovarian cancer progression and chemoresistance via regulating Hippo signaling pathway.Tao Han, Tingsong Chen, Lujun Chen
|May 31, 2022
Multicenter phase II trial of Camrelizumab combined with Apatinib and Eribulin in heavily pretreated patients with advanced triple-negative breast cancer.Jieqiong Liu, Ying Wang, Zhenluan Tian
|Mar 03, 2022
Downregulation of MUC15 by miR-183-5p.1 promotes liver tumor-initiating cells properties and tumorigenesis via regulating c-MET/PI3K/AKT/SOX2 axis.Tao Han, Hao Zheng, Jin Zhang
|Dec 10, 2019
miR-552 promotes ovarian cancer progression by regulating PTEN pathway.Wenman Zhao, Tao Han, Bao Li
Pageof 1
